BRAF Mutation Status Concordance Between Primary Cutaneous Melanomas and Corresponding Metastases: A Review of the Latest Evidence. / Concordancia mutacional de BRAF entre melanoma primario cutáneo y sus correspondientes metástasis. Revisión de la evidencia actual.
Actas Dermosifiliogr
; 108(10): 894-901, 2017 Dec.
Article
en En, Es
| MEDLINE
| ID: mdl-28711165
ABSTRACT
The identification of B-Raf proto-oncongene (BRAF) mutation and the emergence of targeted therapy marked a turning point in the treatment of melanoma. The study of mutation status concordance between primary tumors and metastases in this cancer has major treatment implications as it facilitates the selection of candidates for targeted therapy. This review analyzes the evidence on the level of mutation status concordance between primary tumors and different types of metastases in cutaneous melanoma and provides an overview of the advantages and disadvantages of the various methods used to detect BRAF mutations.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Oncogenes
/
Neoplasias Cutáneas
/
Proteínas Proto-Oncogénicas B-raf
/
Melanoma
/
Mutación
/
Proteínas de Neoplasias
Límite:
Humans
Idioma:
En
/
Es
Año:
2017
Tipo del documento:
Article